Most Recent
Boral has asked the Full Court to hear its appeal of a decision allowing its former CEO to be questioned about an email that mentioned a confidential EY report.
Logistics giant Qube has won a $40 million cut to amounts owed to Martinus Rail in a dispute over construction of the Moorebank terminal project in Sydney's west.
ANZ has lost its appeal of a landmark decision finding it breached continuous disclosure rules by failing to disclose a $750 million bailout by underwriters during a $2.5 billion capital raising.
The developer of the blockbuster horror video game Dead by Daylight has succeeded in revoking the trade mark of rival developer of a virtual sporting game.
A vaccine developer cannot prevent Flinders University from blocking his access to a research lab and interfering with the supply of mice for research relating to COVID-19 and other diseases.
Mills Oakley has lured three partners from rival firms to join its offices in Perth, Brisbane and Adelaide.
Samsung Bioepis can't get indemnity costs from Janssen Biotech after it surrendered patents for Crohn’s disease drug Stelara and filed a fresh case based on new patents for the drug.
A class action by frustrated buyers over the $85 million sale of a Sydney development has failed to prevent the sale of lots, with a judge finding the class action's claims lack evidence.
The ACCC will not oppose Lendlease’s plan to sell a portfolio of residential projects to Stockland for $1.3 billion after accepting Stockland’s plan to divest a project in Illawarra.
An insurer has asked the High Court to hear an appeal with implications for competition in the "monopolised" market for lawyers professional indemnity insurance in New South Wales.